Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
A CU TE M YELO BLAS T I C L E U K E MIA (AML) What is AML? AML is a cancer of the white blood cells. In most cases of AML, the body makes too many white blood cells called myeloblasts. ese immature blood cells cannot ght infection as well as normal white blood cells do. As more myeloblasts are made, they keep normal blood cells from growing. is can lead to infections, bleeding problems, and anemia (loss of red blood cells) and threaten major organs, such as the brain and spinal cord, if not treated quickly. Other names for AML Acute myeloid leukemia Acute myelogenous leukemia Acute granulocytic leukemia Who gets AML? Adults over the age of 65 years are most likely to get AML. But it can What happens with treatment? AML must be treated quickly because the patient type of leukemia may be treated with: Chemotherapy — Uses drugs to kill cancer cells. Drugs that go into the bloodstream can reach cancer cells in most parts of the body. Drugs that that spread to the brain and spinal cord. ect people at any age. Radiation therapy — Uses high-energy x-rays to kill cancer cells. Radiation therapy may be given to patients with high-risk leukemia to treat cancer cells in the brain and spinal cord. e treatment may also keep cancer cells from spreading to those parts of the body. Stem cell transplantation — Replaces blood cells killed er high-dose chemotherapy and radiation with stem cells that can make new blood cells. Immunotherapy — Uses drugs that kill cancer cells directly or help the immune system kill those cells. about a remission. This means that: No myeloblasts are seen in the blood or bone marrow (the so tissue inside the bones where blood cells l aree made). e body is making normal blood cells and blood counts return to normal. e body function returns to normal and health and well-being are restored. ere is no sign of AML in any other part of the body. A CU TE M YELO BLAS T I C L E U K E MIA (AML) What happens first? How to make it easier to get through treatment Chemotherapy can injure any cell in the body that grows or divides Phases of Chemotherapy for AML Phase 1: Induction Getting high doses of drugs to kill cancer cells in the blood and bone marrow and bring about a remission Phase 2: Postremission Getting high doses of drugs to kill any cancer cells that transplantation may also be done Infection Hair loss Nausea Mouth sores Vomiting Diarrhea Patients who have certain types of cancer or are starting some kinds of chemotherapy may also be at risk for tumor lysis syndrome (TLS). TLS may damage the kidneys, heart, and other organs when large numbers of high-risk patients are treated before they start chemotherapy. Tips on how to cope with the side effects of treatment: How do we know if the treatment is working? Tests show how well treatment is working and check for any health problems. Complete blood count Measures the number of each type of blood cell Blood chemistry tests Check for abnormal levels of certain chemicals in the body that could be signs of health problems Bone marrow aspiration Shows if there are cancer cells in the bone marrow Lumbar puncture or spinal tap Report signs of infection (such as a fever) and health concerns to the doctor or nurse as soon as you notice them. to the doctor or nurse. Tell the medical team about all other medicines the patient is taking. Wher e to learn more Learn how to care for the central line (the tube in the chest through which chemotherapy is given). And be sure to ask the nurses for other self-care tips. Nurses are great teachers. ukemia & Lymphoma Society www.lls.org 800-955-4572 and take care of the teeth and gums. Ask about medicines to control National Cancer Institute www.cancer.gov/leukemia 800-4-CANCER (422-6237) People Living With Cancer www.plwc.org 888-651-3038 from getting worse. Share feelings with others. Patient Counseling Program Provided as an educational service by ©2012 sanofi-aventis U.S. LLC US.RAS.12.04.005 April 1012